According to our report, the size of the global cell-based assay market is estimated to grow USD 14.4 billion in 2020. This value is expected to be growing at a CAGR of 11.31% to reach USD 24.7 billion by 2025.
Cell-based assays are majorly used by biotechnology companies, academic research institutes, contract research organizations, government institutions, pharmaceutical companies, etc. The cell-based assay is a technique of examining living cells based on diverse parameters. Cell-based assays are used to determine virtually the functions of cellular or biochemical processes. In cell-based assays, functional cells are used as analytical tools in research for novel drugs. Cell-based assays ease research in the area of immunology, stem cells, cancer, and others.
MARKET DRIVERS:
Growing research activities in drug discovery, technological development, an increase in demand for biological drugs, government spending, increasing the need for toxicity screening in drugs are likely to drive the market for cell-based assays. Additionally, the essential advantages of a cell-based assay, innovation in technologically advanced products, and the need to decrease costs associated with drug discovery are anticipated to drive the market for cell-based assays.
The cell-based assay market is likely to expand during the forecast period owing to growth opportunities such as untapped market areas in developing countries, increasing applications of cell-based assays in immunology, cancer, and stem cells, and increasing adoption of label-free cell-based assays.
MARKET RESTRAINTS:
However, short of skilled professionals, severe intellectual property rights, and the high cost of instruments restraining the growth of the global cell-based assays market.
Impact of COVID-19 on the global cell-based assays market:
COVID 19 pandemic was announced as an emergency public health issue by the World Health Organization (WHO), which has disrupted many sectors and the medical field. The development of a vaccine for the coronavirus is a major challenging factor for pharmaceutical companies to curb the spread of the disease. Focusing on developing an efficient vaccine with all the latest techniques available and making it available for the people in very little time has enhanced the demand of the cell-based assay market. In research and development activities, the cell-based assay techniques play a major role in assessing the structure of the COVID 19 on the human body. The market shares to continue in the same flow in the coming years.
REPORT COVERAGE:
|
REPORT METRIC |
DETAILS |
|
Market Size Available |
2019 to 2025 |
|
Base Year |
2019 |
|
Forecast Period |
2020 to 2025 |
|
Segments Covered |
By Type of Product, Technology, Application, End-User, and Region |
|
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
|
Regions Covered |
North America, Europe, Asia Pacific, Latin America, Middle East, and Africa |
This market research report on the global cell-based assay market has been segmented and sub-segmented based on the type of product, technology, application, end-user, and region.
Cell-Based Assay Market - By Type of Product:
Based on product type, the consumables and reagent segment are ruling the market and are expected to continue the trend during the forecast period due to the growing focus on drug discovery activities in developing countries leading to increasing cell-based assays in drug discovery.
Cell-Based Assay Market - By Technology:
Cell-Based Assay Market - By Application:
Based on the application, the drug discovery segment is ruling the market. It is likely to expand with a high CAGR during the forecast period owing to rising funds for Research and development by governments and biopharmaceutical companies.
Cell-Based Assay Market - By End Users:
Cell-Based Assay Market - By End Users:
Regionally, North America, followed by Europe, has the biggest market for cell-based assays due to rising drug-related research & development activities, an increase in adoption of cell-based assay platforms, and a considerable number of pharmaceutical and biotechnology companies in this region. The growth of the North American market is majorly driven by the factors such as increasing awareness about cell-based assays used for drug discovery and the extensive adoption of cell-based therapies. The growing incidence of chronic diseases such as cancer and diabetes is further boosting the market's growth rate. The United States is leading the cell-based assays market with increasing funds and investments for the research activities to develop drugs. Canada is quickly growing after the United States in the region. According to the American Cancer Society, in 2019, around 1.9 million new cancer cases are registered in the U.S. Surging approvals for the clinical trials for stem cell therapy are accelerating the cell-based assays market.
The European market stood 2nd in place in accounting for the leading shares in the global market in 2019and projected to showcase promising growth during the forecast period. Factors such as increasing consciousness regarding the cell-based assays and increasing adoption of cell-based assays in R&D activities are propelling the growth rate of the market.
Asia is expected to show a high growth rate in the cell-based assays market in the next few years. Growth in the APAC region is due to rising infrastructural development, growing funds in research and development by various private and public organizations in enhancing safer and better drugs, and high adoption of high throughput screening methods. The Chinese market is projected to rule the Asia Pacific cell-based assays market. It is driven by the growing number of biotechnology and pharmaceutical industry sectors and surging huge demand for cell-based assays. Countries such as India and Japan were considered to have the highest growth rate during the analysis period. The Indian cell-based assays market is assumed to have showcased a healthy CAGR growth rate over the period. They intensify the number of chronic diseases and surging obtainment of extraordinary research facilities during the forecast period. The Japanese market is expected to have a quick growth within a short period in the APAC region. The growing number of cancer cases, rising toxicity for examination, and drug identification are escalating the cell-based assays market. Also, the colossal expenditure made by the government accelerates the market's growth rate.
KEY MARKET PARTICIPANTS AND SHARE INSIGHTS:
Some of the companies playing a dominating role in the Global Cell-Based Assay Market profiled in this report are Thermo Fisher Scientific Inc., Becton, Dickinson and Company, Merck & Co. Inc., Cell Signalling Technology Inc., PerkinElmer Inc., Danaher Corporation, Cisbio Bioassays, DiscoveRx, Ametek Inc., Bio-Rad Laboratories, Roche Diagnostics, GE Healthcare, and Promega Corporation.
Currently, Thermo Fisher Scientific and Danaher Corporation are the top 2 companies in the global cell-based assay market. Key market participants majorly focus on the R&D, organic and inorganic strategies to maintain and further strengthen their market position.
In 2019, Danaher Company launched ClearLLAb 10C System for Flow cytometry labs.
In 2019, PerkinElmer completed the acquisition of Cisbio Bioassays.
In 2018, GE Healthcare inaugurated a new testing center to enhance its research and manufacturing capabilities.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Type of Product
5.1.1 Introduction
5.1.2 Cell Lines
5.1.2.1 Primary Cell Lines
5.1.2.2 Stem Cell Lines
5.1.2.3 Immortalized Cell Lines
5.1.3 Assay Ready Kits
5.1.4 Cell Culture Kits
5.1.5 Reagents & Consumables
5.1.6 Ligands & Inhibitors
5.1.7 Y-o-Y Growth Analysis, By Type of Product
5.1.8 Market Attractiveness Analysis, By Type of Product
5.1.9 Market Share Analysis, By Type of Product
5.2 Technology
5.2.1 Introduction
5.2.2 Automated Handling
5.2.3 Flow Cytometry
5.2.4 Label-Free Detection
5.2.5 High Content Screening
5.2.6 High Throughput Screening
5.2.7 Y-o-Y Growth Analysis, By Technology
5.2.8 Market Attractiveness Analysis, By Technology
5.2.9 Market Share Analysis, By Technology
5.3 Application
5.3.1 Introduction
5.3.2 Drug Discovery
5.3.3 ADME Research
5.3.7 Y-o-Y Growth Analysis, By Application
5.3.8 Market Attractiveness Analysis, By Application
5.3.9 Market Share Analysis, By Application
5.4 End User
5.4.1 Introduction
5.4.2 Academia
5.4.3 Biotechnology
5.4.4 Pharmaceuticals
5.4.5 CRO
5.4.6 Y-o-Y Growth Analysis, By End User
5.4.7 Market Attractiveness Analysis, By End User
5.4.8 Market Share Analysis, By End User
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Type of Product
6.1.3.3 By Technology
6.1.3.4 By Application
6.1.3.5 By End User
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Type of Product
6.1.4.3 By Technology
6.1.4.4 By Application
6.1.4.5 By End User
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Technology
6.1.5.3 By Type
6.1.5.4 By Application
6.1.5.5 By End User
6.2 North America
6.1.1 Introduction
6.1.2 United States
6.1.3 Canada
6.3 Europe
6.2.1 Introduction
6.2.2 U.K
6.2.3 Spain
6.2.4 Germany
6.2.5 Italy
6.2.6 France
6.4 Asia-Pacific
6.3.1 Introduction
6.3.2 China
6.3.3 India
6.3.4 Japan
6.3.5 Australia
6.3.6 South Korea
6.5 Latin America
6.4.1 Introduction
6.4.2 Brazil
6.4.3 Argentina
6.4.4 Mexico
6.4.5 Rest of Latin America
6.6 Middle East & Africa
6.5.1 Introduction
6.5.2 Middle-East
6.5.3 Africa
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Thermo Fisher Scientific Inc.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Becton
8.3 Dickinson and Company
8.4 Merck & Co. Inc.
8.5 Cell Signalling Technology Inc.
8.6 PerkinElmer Inc.,
8.7 Danaher Corporation
8.8 General Electric Company
8.9 Cisbio Bioassays
8.10 DiscoveRx
8.11 Ametek Inc.
8.12 -Rad Laboratories
8.13 Roche Diagnostics
8.14 GE Healthcare
8.15 Promega Corporation
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
